The kynurenine pathway and parasitic infections that affect CNS function.
about
Meat Intake and the Dose of Vitamin B3 - Nicotinamide: Cause of the Causes of Disease Transitions, Health Divides, and Health Futures?The human immune response to Toxoplasma: Autophagy versus cell death.Major developments in the design of inhibitors along the kynurenine pathway.The kynurenine pathway and the brain: Challenges, controversies and promises.Cerebrospinal fluid kynurenine and kynurenic acid concentrations are associated with coma duration and long-term neurocognitive impairment in Ugandan children with cerebral malariaInhibition of hypoxia-associated response and kynurenine production in response to hyperbaric oxygen as mechanisms involved in protection against experimental cerebral malaria.Case Series of Severe Neurologic Sequelae of Ebola Virus Disease during Epidemic, Sierra LeoneAcute Infection in Cats Induced Tissue-Specific Transcriptional Response Dominated by Immune Signatures
P2860
Q33642585-5C16AFB3-58BB-4CEB-98AA-6148BF08AFAEQ36302336-ED752F6C-CFA7-43B8-B9DE-38CCC600A9F5Q38808400-0F5DFA46-634D-4529-BE8A-5F8088F2550BQ38832497-AD660180-8DF9-4BFD-A8A6-214D68279119Q38849464-36978579-4A30-4D98-BCD3-4C0D79F6F89AQ52725478-9B9AE2B9-36E5-4DD2-BAD3-D3852C886800Q56949127-61076D4E-E7E6-46D0-A82A-3F741F03974BQ58587557-50E10132-F7BD-4613-BC88-94781B799E10
P2860
The kynurenine pathway and parasitic infections that affect CNS function.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The kynurenine pathway and parasitic infections that affect CNS function.
@en
type
label
The kynurenine pathway and parasitic infections that affect CNS function.
@en
prefLabel
The kynurenine pathway and parasitic infections that affect CNS function.
@en
P2093
P50
P1433
P1476
The kynurenine pathway and parasitic infections that affect CNS function.
@en
P2093
Jintao Guo
Lay Khoon Too
Loke Tim Khaw
Nicholas H Hunt
P304
P356
10.1016/J.NEUROPHARM.2016.02.029
P577
2016-02-25T00:00:00Z